Alcedis

Alcedis is a contract research organization (CRO) that focuses on data-driven clinical trials. The company provides end-to-end services, including consulting, planning, and execution of clinical studies for the life science sector.

Its core business model revolves around combining traditional clinical trial services with its proprietary technology platform, also named Alcedis. This platform is designed for multi-channel data sourcing and is augmented by an artificial intelligence incubator lab, developed through a strategic academic partnership. This integration allows the firm to manage and analyze complex data sets in clinical research, aiming to accelerate progress in human health. The company serves clients such as pharmaceutical companies and research institutions, as evidenced by its involvement in studies for conditions like breast cancer, rheumatoid arthritis, and diabetes.

In 2023, Alcedis was acquired by Huma Therapeutics, a move that combines its clinical trial expertise with Huma's digital health platform. This acquisition positions the entity to offer more comprehensive digital research solutions globally.

Keywords: Contract Research Organization, clinical trials, data science, life sciences, digital health, AI, data engineering, scientific research, Huma Therapeutics, Alcedis platform